Accession Number: | 0001567619-20-012487 |
Date: | 2020-06-18 |
Issuer: | GRITSTONE ONCOLOGY, INC. (GRTS) |
Original Submission Date: |
KROGNES STEVE E.
C/O GRITSTONE ONCOLOGY, INC.
5959 HORTON STREET, SUITE 300
EMERYVILLE, CA 94608
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 6.66 | 2020-06-18 | deemed execution date | A | 12,500 (a) | 2030-06-18 | common stock 12,500 | $6.66 | 12,500 | direct |
ID | footnote |
---|---|
f1 | the option will vest and become exercisable on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date. |